SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

European Commission Approves Incyte’s Povofortay for Hidradenitis Suppurativa

The European Commission approved Povofortay (povorcitinib) 45 mg and 75 mg for eligible adults with moderate to severe hidradenitis suppurativa.

INCY

Related stories